peptide
5 articles tagged with ‘peptide’
CJC-1295 and Ipamorelin: Human Evidence and Limits
This reference separates what human trials, animal models, and analytical chemistry show about CJC-1295 and ipamorelin from vendor marketing, assessing the strength of the human evidence base and combination-specific safety data.
Retatrutide in Canada: Access, Trials, and Approval Timing
Retatrutide is not yet approved in Canada; access is limited to clinical trials. This article outlines the current status, evidence, and realistic timelines for availability.
CJC-1295 and Ipamorelin Dosage: Evidence and Risks
This reference reviews the evidence on CJC-1295 and ipamorelin dosing, distinguishing what controlled studies support from what remains speculative or vendor-derived.
Insulin: Discovery in 1921, Structure, and Key Properties
Insulin, discovered by Banting and Best in 1921, evolved from animal pancreas extracts to highly pure recombinant human versions exceeding 98% purity. This 51-amino acid hormone features two chains linked by disulfide bonds and forms hexamers with zinc for storage and stability. Modern formulations include phenolic preservatives that trigger a conformational shift, alongside agents for isotonicity and buffering, matching natural secretion patterns of 60-80 μU/mL post-meal peaks and 5-15 μU/mL basal levels.
Semax: Guide to the ACTH-Derived Nootropic Peptide
Semax is a synthetic heptapeptide from the ACTH(4-7) sequence, developed in Russia during the 1980s for neuroprotective and cognitive effects. Research shows it upregulates BDNF and TrkB, improves outcomes in ischemia models, and enhances learning in rodents. This guide covers its structure, mechanisms, and research applications while noting variants like N-Acetyl Semax.